StockData
Neuronetics, Inc. logo

Neuronetics, Inc. (STIM) stock

STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$1.25+0.01 (+0.81%)

Close on Nov 20, 2026Market cap $95.25MP/E –Yield –

Neuronetics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Neuronetics's free cash flow for the twelve months ending Jun 30, 2026 was -$11.28M. For fiscal 2025 it was -$21.20M. The highest annual figure on record is -$8.87M in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.20M–
FY2024Dec 31, 2024-$32.46M–
FY2023Dec 31, 2023-$34.41M–
FY2022Dec 31, 2022-$34.01M–
FY2021Dec 31, 2021-$30.34M–
FY2020Dec 31, 2020-$29.12M–
FY2019Dec 31, 2019-$31.30M–
FY2018Dec 31, 2018-$21.60M–
FY2017Dec 31, 2017-$11.74M–
FY2016Dec 31, 2016-$8.87M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.43M–
Q1 FY2026Mar 31, 2026-$9.62M–
Q4 FY2025Dec 31, 2025$666.00K–
Q3 FY2025Sep 30, 2025-$899.00K–
Q2 FY2025Jun 30, 2025-$3.76M–
Q1 FY2025Mar 31, 2025-$17.21M–
Q4 FY2024Dec 31, 2024-$8.69M-792.6%
Q3 FY2024Sep 30, 2024-$5.80M–
Q2 FY2024Jun 30, 2024-$5.59M–
Q1 FY2024Mar 31, 2024-$12.39M–
Q4 FY2023Dec 31, 2023$1.25M–
Q3 FY2023Sep 30, 2023-$10.68M–
Q2 FY2023Jun 30, 2023-$9.54M–
Q1 FY2023Mar 31, 2023-$15.45M–
Q4 FY2022Dec 31, 2022-$3.60M–
Q3 FY2022Sep 30, 2022-$7.23M–
Q2 FY2022Jun 30, 2022-$9.92M–
Q1 FY2022Mar 31, 2022-$13.26M–
Q4 FY2021Dec 31, 2021-$5.33M–
Q3 FY2021Sep 30, 2021-$8.96M–
Q2 FY2021Jun 30, 2021-$6.21M–
Q1 FY2021Mar 31, 2021-$9.84M–
Q4 FY2020Dec 31, 2020-$1.82M–
Q3 FY2020Sep 30, 2020-$3.69M–
Q2 FY2020Jun 30, 2020-$9.70M–
Q1 FY2020Mar 31, 2020-$13.92M–
Q4 FY2019Dec 31, 2019-$6.76M–
Q3 FY2019Sep 30, 2019-$7.72M–
Q2 FY2019Jun 30, 2019-$6.97M–
Q1 FY2019Mar 31, 2019-$9.84M–
Q4 FY2018Dec 31, 2018-$2.64M–
Q3 FY2018Sep 30, 2018-$5.06M–
Q2 FY2018Jun 30, 2018-$5.32M–
Q1 FY2018Mar 31, 2018-$8.59M–
Q4 FY2017Dec 31, 2017-$7.00K–
Q3 FY2017Sep 30, 2017-$2.10M–

More Neuronetics figures

See a number that looks wrong?